UMB Bank’s Core Laboratories CLB Stock Holding History

UMB Bank’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.7K	Sell	232 -186	-44%	-$2.65K	﹤0.01%	2170
2026 Q1	$7.02K	Buy	418 +15	+4%	+$268	﹤0.01%	1961
2025 Q4	$6.46K	Buy	403 +215	+114%	+$3.2K	﹤0.01%	1956
2025 Q3	$2.32K	Buy	+188	New	+$2.2K	﹤0.01%	2032
2025 Q2	–	Sell	-186	Closed	-$2.79K	–	2134
2025 Q1	$2.79K	Sell	186 -254	-58%	-$4.25K	﹤0.01%	1910
2024 Q4	$7.62K	Sell	440 -135	-23%	-$2.6K	﹤0.01%	1564
2024 Q3	$10.7K	Sell	575 -223	-28%	-$4.48K	﹤0.01%	1455
2024 Q2	$16.2K	Sell	798 -163	-17%	-$2.88K	﹤0.01%	1145
2024 Q1	$16.4K	Buy	+961	New	+$15.1K	﹤0.01%	1151

Other funds holding CLB

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CAMG

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

UMB Bank's CLB Position: Q2 2026 in Review

UMB Bank reduced its Core Laboratories (CLB) stake by 44% in Q2 2026, selling an estimated $2.65K and leaving 232 shares worth $2.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2170.

UMB Bank first reported a position in CLB in Q1 2024 and has held it in 9 quarters since. The position peaked at $16.4K in Q1 2024. 187 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

UMB Bank held 232 shares of Core Laboratories worth $2.7K as of Q2 2026.
UMB Bank sold 186 Core Laboratories shares in Q2 2026, an estimated $2.65K.
Core Laboratories made up ﹤0.01% of UMB Bank's portfolio in Q2 2026, its #2170 holding.
UMB Bank first reported a position in Core Laboratories in Q1 2024 and has held it in 9 quarters since.
UMB Bank's Core Laboratories position peaked at $16.4K in Q1 2024.
187 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.